In addition, we demonstrated that translation defects are cell autonomous and can be rescued by therapies increasing SMN protein levels, suggesting that defects in translation and ribosome biology are core pathological hallmarks of SMA. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.